Copyright
©The Author(s) 2015.
World J Gastroenterol. Dec 7, 2015; 21(45): 12787-12799
Published online Dec 7, 2015. doi: 10.3748/wjg.v21.i45.12787
Published online Dec 7, 2015. doi: 10.3748/wjg.v21.i45.12787
Figure 7 Effects of GW501516 on reactive oxygen species production and associated molecular pattern-activated protein kinase-α phosphorylation in HepG2 cells.
Intracellular ROS production was quantified using the fluorescent probe 2′,7′-dichlorodihydrofluorescein diacetate (DCFDA) (A). GW501516 inhibited lipopolysaccharide (LPS)- and palmitic acid (PA)-induced ROS generation. Representative immunoblot and graphic presentation of p-AMPK-α and total AMPK-α protein levels in HepG2 cells are shown (B). GW501516 tended to increase the phosphorylation of AMPK-α in PA- and LPS-treated cells. Data are expressed as the mean ± SD (5-6 mice per group). aP < 0.05 vs control cells, cP < 0.05 vs PA + LPS-treated cells.
- Citation: Lee HJ, Yeon JE, Ko EJ, Yoon EL, Suh SJ, Kang K, Kim HR, Kang SH, Yoo YJ, Je J, Lee BJ, Kim JH, Seo YS, Yim HJ, Byun KS. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease. World J Gastroenterol 2015; 21(45): 12787-12799
- URL: https://www.wjgnet.com/1007-9327/full/v21/i45/12787.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i45.12787